Following the meltdown at Three Mile Island nuclear plant in 1979, ANBEX developed iOSAT for protection from an accidental or terrorist related release of radioactive iodine from a nuclear power plant or nuclear weapon.

iOSAT received its approval from the US Food and Drug Administration in 1982, and is the only full-strength tablet for radiation blocking which may legally be sold in the US.

Only iOSAT has passed all FDA tests for purity, quality, safety and efficacy.

iOSAT potassium iodide by Anbex

Each package includes 14 tablets with 130 mg potassium iodide.